KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Depreciation & Amortization (CF) (2020 - 2025)

AbCellera Biologics' Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $5.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 142.86% year-over-year to $5.1 million, compared with a TTM value of $18.3 million through Dec 2025, up 46.4%, and an annual FY2025 reading of $18.4 million, up 46.77% over the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $5.1 million at AbCellera Biologics, up from $4.3 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $5.1 million in Q4 2025, with the low at $800000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $2.9 million, with a median of $2.9 million recorded in 2023.
  • Year-over-year, Depreciation & Amortization (CF) plummeted 45.57% in 2024 and then soared 142.86% in 2025.
  • Tracing ABCL's Depreciation & Amortization (CF) over 5 years: stood at $1.3 million in 2021, then soared by 114.89% to $2.8 million in 2022, then soared by 37.79% to $3.9 million in 2023, then plummeted by 45.57% to $2.1 million in 2024, then skyrocketed by 142.86% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Depreciation & Amortization (CF) are $5.1 million (Q4 2025), $4.3 million (Q3 2025), and $4.5 million (Q2 2025).